These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11504090)

  • 1. Radiation exposure and radiation protection of the physician in iodine-131 Lipiodol therapy of liver tumours.
    Risse JH; Ponath C; Palmedo H; Menzel C; Grünwald F; Biersack HJ
    Eur J Nucl Med; 2001 Jul; 28(7):914-8. PubMed ID: 11504090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe radiation exposure of medical personnel by using simple methods of radioprotection while administering 131I-lipiodol therapy for hepatocellular carcinoma.
    Garin E; Laffont S; Rolland Y; Olivie D; Lecloirec J; Herry JY; Boucher E; Raoul JL; Bourguet P
    Nucl Med Commun; 2003 Jun; 24(6):671-8. PubMed ID: 12766603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-arterial radionuclide therapy for liver tumours: effect of selectivity of catheterization and 131I-Lipiodol delivery on tumour uptake and response.
    Brans B; Bacher K; Vandevyver V; Vanlangenhove P; Smeets P; Thierens H; Dierckx RA; Defreyne L
    Nucl Med Commun; 2003 Apr; 24(4):391-6. PubMed ID: 12673167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
    Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE
    Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol (Br J Surg 2003; 90: 1379-1383).
    Rai R; Rai S
    Br J Surg; 2004 Mar; 91(3):373; author reply 373. PubMed ID: 14991642
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
    Leung WT; Lau WY; Ho S; Chan M; Leung N; Lin J; Ho KC; Metreweli C; Johnson PJ; Li AK
    J Nucl Med; 1994 Aug; 35(8):1313-8. PubMed ID: 7519259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study.
    Brans B; De Winter F; Defreyne L; Troisi R; Vanlangenhove P; Van Vlierberghe H; Lambert B; Praet M; de Hemptinne B; Dierckx RA
    Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation protection in radiosynovectomy of the knee.
    Liepe K; Andreeff M; Wunderlich G; Kotzerke J
    Health Phys; 2005 Aug; 89(2):151-4. PubMed ID: 16010126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioiodine therapy: care of the helpless patient and handling of the radioactive corpse.
    Greaves C; Tindale W
    J Radiol Prot; 2001 Dec; 21(4):381-92. PubMed ID: 11787894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hepatocellular carcinoma (HCC) with radiolabeled Lipiodol: a preliminary report.
    Park CH; Suh JH; Yoo HS; Lee JT; Kim DI; Kim BS
    Nucl Med Commun; 1987 Dec; 8(12):1075-87. PubMed ID: 2835716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of β-radiation exposure during preparation of 188Re-labelled Lipiodol for hepatocellular carcinoma treatment.
    Lepareur N; Laffont S; Ardisson V; Noiret N; Garin E
    Nucl Med Commun; 2012 Feb; 33(2):205-8. PubMed ID: 22124362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil.
    Yoo HS; Lee JT; Kim KW; Kim BS; Choi HJ; Lee KS; Park CI; Park CY; Suh JH; Loh JJ
    Cancer; 1991 Nov; 68(9):1878-84. PubMed ID: 1717129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting.
    Novell JR; Hilson AJ
    J Nucl Med; 1994 Aug; 35(8):1318-20. PubMed ID: 8046486
    [No Abstract]   [Full Text] [Related]  

  • 14. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study.
    Partensky C; Sassolas G; Henry L; Paliard P; Maddern GJ
    Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small hepatocellular carcinoma: high dose internal radiation therapy with superselective intra-arterial injection of I-131-labeled Lipiodol.
    Yoo HS; Park CH; Lee JT; Kim KW; Yoon CS; Suh JH; Park CY; Kim BS; Choi HJ; Lee KS
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S128-33. PubMed ID: 8137473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report of a pilot study of intra-arterial injection of I-131 lipiodol for the treatment of hepatoma.
    Lui WY; Liu RS; Chiang JH; Lo JG; Lai KH; King KL; Cheng HC; Wei YY; Chi CW; P'eng FK
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Sep; 46(3):125-33. PubMed ID: 2178041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma.
    Toubeau M; Touzery C; Berriolo-Riedinger A; Cochet A; Brunotte F; Bedenne L; Cercueil JP; Krause D
    Eur J Nucl Med; 2001 May; 28(5):669-70. PubMed ID: 11383874
    [No Abstract]   [Full Text] [Related]  

  • 18. Thyroid uptake and radiation dose after (131)I-lipiodol treatment: is thyroid blocking by potassium iodide necessary?
    Bacher K; Brans B; Monsieurs M; De Winter F; Dierckx RA; Thierens H
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1311-6. PubMed ID: 12271412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure of medical personnel to radiation during radionuclide therapy practices.
    Lancelot S; Guillet B; Sigrist S; Bourrelly M; Waultier S; Mundler O; Pisano P
    Nucl Med Commun; 2008 Apr; 29(4):405-10. PubMed ID: 18317307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
    De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H
    J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.